San Diego-based aTyr Pharma raised $49 million in Series D equity financing and secured a $10 million loan to support clinical development of therapeutics for autoimmune diseases.
An undisclosed global public investment fund made an equity investment in aTyr alongside the company's existing venture capital investors Alta...






![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
